Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-06

Clinical Trial Update: Cyclobenzaprine Extended Release (ER) for Fibromyalgia [Phase 4]

View source ↗

Summary

Phase 4 trial of cyclobenzaprine extended-release for fibromyalgia was terminated, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclobenzaprine ER (cyclobenzaprine)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Fibromyalgia, Pain | Phase 4 | Status: TERMINATED | Results posted: 2021-10-06